LEAP THERAPEUTICS INC (LPTX) Stock Analyst Earnings Estimates
NASDAQ:LPTX - Nasdaq - US52187K2006 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.5M | 1.5M | 1.224M -100.00% | 9.882M | 19.749M 99.85% | 78.933M 299.68% | 160.94M 103.89% | 361.23M 124.45% | 541.08M 49.79% | ||||||
| EBITDA YoY % growth | -33.4M -8.79% | -28.51M 14.64% | -41.4M -45.21% | N/A -37.05% | N/A -53.38% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.45M -8.78% | -28.54M 14.68% | -41.43M -45.16% | -56.986M -37.00% | -89.903M -53.35% | -71.224M 18.17% | -63.344M 11.06% | -73.044M -15.31% | -61.846M 15.33% | -72.551M -17.31% | -9.753M 86.56% | 70.646M 824.37% | 198.21M 180.57% | 335.49M 69.26% | |
| Operating Margin | N/A | -1,902.67% | -2,762.00% | -4,655.71% | N/A | N/A | N/A | N/A | -625.85% | -367.36% | -12.36% | 43.90% | 54.87% | 62.00% | |
| EPS YoY % growth | -1.50 -16.28% | -0.55 63.33% | -0.48 12.73% | -4.98 -879.17% | -4.18 -8.09% | -1.87 63.16% | -1.29 31.06% | -1.20 6.72% | -1.27 -5.36% | -1.12 11.53% | -0.31 72.73% | 0.03 110.00% | 0.77 2,400.00% | 1.64 114.67% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.40 14.08% | -0.37 26.67% | -0.35 33.31% | -0.32 27.36% | -0.32 20.00% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.531M -11.54% | -17.049M -15.00% | -15.853M 25.41% | -15.235M 14.67% | -15.801M 4.41% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.44 13.73% | -0.49 | 0.05 | 10.13% |
| Q2 2024 Q2Q % growth | -0.52 42.86% | -0.44 | -0.08 | -18.56% |
| Q1 2024 Q2Q % growth | -0.51 84.06% | -0.60 | 0.09 | 14.53% |
| Q4 2023 Q2Q % growth | -0.46 54.00% | -0.56 | 0.10 | 18.00% |
| Q3 2023 Q2Q % growth | -0.51 60.77% | -0.59 | 0.08 | 13.49% |
| Q2 2023 Q2Q % growth | -0.91 39.33% | -0.91 | 0.00 | 0.43% |
| Q1 2023 Q2Q % growth | -3.20 -255.56% | -1.00 | -2.20 | -220.13% |
| Q4 2022 Q2Q % growth | -1.00 -900.00% | -1.12 | 0.12 | 10.87% |
| Q3 2022 Q2Q % growth | -1.30 -828.57% | -1.22 | -0.08 | -6.21% |
| Q2 2022 Q2Q % growth | -1.50 -1,150.00% | -0.98 | -0.52 | -53.19% |
| Q1 2022 Q2Q % growth | -0.90 -650.00% | -1.02 | 0.12 | 11.76% |
| Q4 2021 Q2Q % growth | -0.10 -11.11% | -0.11 | 0.01 | 10.87% |
| Q3 2021 Q2Q % growth | -0.14 -55.56% | -0.11 | -0.03 | -22.55% |
| Q2 2021 Q2Q % growth | -0.12 | -0.13 | 0.01 | 5.88% |
| Q1 2021 Q2Q % growth | -0.12 52.00% | -0.11 | -0.01 | -10.99% |
| Q4 2020 Q2Q % growth | -0.09 72.73% | -0.09 | 0.00 | -0.27% |
| Q3 2020 Q2Q % growth | -0.09 72.73% | -0.13 | 0.04 | 31.07% |
| Q2 2020 Q2Q % growth | -0.12 67.57% | -0.18 | 0.06 | 34.64% |
| Q1 2020 Q2Q % growth | -0.25 46.81% | -0.25 | 0.00 | -0.04% |
| Q4 2019 Q2Q % growth | -0.33 | -0.32 | -0.01 | -1.90% |
| Q3 2019 Q2Q % growth | -0.33 | -0.34 | 0.01 | 1.96% |
| Q2 2019 Q2Q % growth | -0.37 | -0.44 | 0.07 | 14.98% |
| Q1 2019 Q2Q % growth | -0.47 | -0.42 | -0.05 | -12.39% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -100.00% | 1.224M | -1.224M | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 77.52K | -77.52K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 159.12K | -159.12K | -100.00% |
| Q4 2021 Q2Q % growth | 380K | 312.12K | 67.88K | 21.75% |
| Q3 2021 Q2Q % growth | 380K | 1.541M | -1.161M | -75.34% |
| Q2 2021 Q2Q % growth | 380K | 311.1K | 68.9K | 22.15% |
| Q1 2021 Q2Q % growth | 380K | 197.625K | 182.375K | 92.28% |
| Q4 2020 Q2Q % growth | 380K | 529.125K | -149.125K | -28.18% |
| Q3 2020 Q2Q % growth | 380K | 1.02M | -640K | -62.75% |
| Q2 2020 Q2Q % growth | 380K | 637.5K | -257.5K | -40.39% |
| Q1 2020 Q2Q % growth | 380K | 2.55M | -2.17M | -85.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 20.51% | 0% | -1.52% |
| Revenue | N/A | N/A | N/A | N/A |